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Human class I major histocompatibility complex allele HLA-B27 is associated with a group of 
human diseases called "spondyloarthropathies."  Studies on transgenic rats expressing HLA-B27 
and  human  132-microglobulin  have  confirmed  the  role  of HLA-B27  in  disease  pathogenesis. 
Here we  report spontaneous  inflammatory  arthritis  in  HLA-B27  transgenic  mice lacking 132- 
microglobulin  (B27+132m-/-).  In the  absence  of 132-microglobulin,  B27+132m -/-  animals  do 
not express the HLA-B27  transgene  on the cell surface and have a very low level of CD8 + T 
cells. Most of the B27+132 m-/-  male mice showed nail changes, hair loss, and swelling in paws, 
which leads to ankylosis. The symptoms occur only after the B27+132 m-/-  mice are transferred 
from  the  specific  pathogen-free  mouse  colony.  These  results  suggest  that  aberrant  assembly, 
transport,  and expression of the HLA-B27 molecule may predispose an individual for develop- 
ment of the disease when exposed to an appropriate environmental trigger. 
O 
ne  of the  strongest linkages known  to  date between 
the presence of an HLA allele and disease susceptibil- 
ity is that of HLA-B27 to inflammatory spondyloarthropa- 
thies in humans (1). Although it is clear that the presence of 
the  HLA-B27  allele predisposes  humans  to the  disease,  its 
role  in  disease  pathogenesis  is unclear.  Studies  on  genetic 
polymorphism suggest that B'2705  and B'2702 alleles pre- 
dispose humans  for disease  development,  while  B'2703  is 
not  associated  (2).  Recent  knowledge  about the  three-di- 
mensional structure of the HLA-B27 molecule and peptide 
elution  studies  suggest  that  peptides  approximately  nine 
amino acids long with arginine at position 2 bind to HLA- 
B27  (3, 4).  Several hypotheses for the association of HLA- 
B27 with the human disease have been proposed, including 
(a) presentation  of arthritogenic  peptide by this MHC  class 
I molecule,  (b)  molecular mimicry of HLA-B27  with  cer- 
tain  microorganisms,  (c)  altered  self,  and  (d)  the  possible 
role of closely linked genes (5). 
Transgenic  rats  expressing  several  copies  of the  HLA- 
B27 and the human 132-microglobulin genes develop a spon- 
taneous  inflammatory  disease  that has  many similarities  to 
human spondyloarthropathy  (6). We have previously dem- 
onstrated  expression  of the  HLA-B27  gene  in  transgenic 
mice (7). Until now, no arthritis,  either spontaneous or in- 
duced,  has been observed in these transgenic mice. To de- 
termine  whether  processing,  assembly,  transport,  and  ex- 
pression of the  HLA-B27  molecule  may play a role in the 
disease  process,  we  introduced  the  HLA-B27  transgene 
into  the  132-microglobulin-deficient  mice.  Spontaneous 
arthritis  was  observed  in  HLA-B27  transgenic  mice  lack- 
ing  132-microglobulin  (B27+132 m-/-)  compared  with 
B27+132m +/- full sibs. An environmental trigger for the de- 
velopment of disease is involved, since mice housed in the 
specific pathogen-free barrier colony are unaffected.  Simi- 
lar to HLA-B27-related human spondyloarthropathies,  male 
animals were primarily affected. Our results suggest that ab- 
errant  assembly and/or  expression  of HLA-B27  may per- 
turb the T  cell repertoire and cause disease development. 
Materials and Methods 
Mice.  The HLA-B27  (B'2705)  transgenic mice used in this 
study have been described elsewhere (7). Mutated  ~2  m-/- mice 
were the kind gift of Dr. B. Koller (8). HLA-B27-positive mice 
from (132  m-/- ￿  HLA-B27)F 1 crosses were intercrossed to obtain 
B27+132m -/-  animals.  The presence of the HLA-B27 transgene 
in the F 2 population was identified by PCR using 3' (CTC TGC 
CTT  GGC  CTT  GCA  GA)  and  5'  (CCA  CTC  CAT  GAG 
GTA TTT CCA)  oligonucleotide sequences.  The homozygous 
mutation in  [32-microglobulin  gene was identified  as previously 
described  by  Koller  et  al.  (8). The  B27+132m  +/-  full  sibs, 
B27-[32 m+/-  full  sibs,  and  B27-[32 m-/-  full  sibs  were  used  as 
controls.  All  the  mice  in  our  study  were  bred  in  the  specific 
pathogen-free barrier facility. 
Flow Cytometric Analysis.  Analysis  of expression of the HLA- 
B27 transgene was performed by flow cytometry. Isolated mono- 
nuclear cells from peripheral  blood were  incubated  with  either 
purified or biotinylated ME-1  (American Type Culture  Collec- 
tion,  R.ockville, MD),  HC10  (heavy chain  specific;  9)  or Ye-2 
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proteins; American Type  Culture  Collection) mAbs for 30 min. 
After washing with BSA (1%) and sodium azide  (0.1%)  contain- 
ing PBS,  cells were incubated with fluorescein-labeled secondary 
antibody (IgG goat anti-mouse Fab'2; Accurate Chemical &  Sci- 
entific  Corp.,  Westbury,  NY)  or  Streptividin-lk-phycoerythrin 
(Tago,  Inc.,  Burlingame,  CA).  Cell-surface  expression was  ana- 
lyzed on 10,000 gated lymphocytes on forward and side scatter by 
flow cytometry. 
Cytotoxicity Assay.  Target Con A blast of spleen cells were la- 
beled with  150  vtCi SlCr (Amersham Corp.,  Arlington Heights, 
IL) for 90 min and placed at 1  )<104 per well in 96-well U-bot- 
tomed plates (Coming Inc., Coming, NY)  in triplicates. Effector 
anti-B27 CTLs used in this study were the kind gift of Dr. Kauf- 
man  and  Dr.  Liebson  (Mayo  Clinic,  Rochester,  MN).  These 
CTLs were  generated from PBLs of a normal healthy individual 
by stimulating them with  irradiated  C1RB27  cells.  Anti-CD14 
mAb and rabbit complement were used to lyse possible NK cells. 
Effector cells (10  s)  (10:1  E/T ratio) were added and incubated at 
37~  for  4  h.  The  supematant was  harvested and counted  in  a 
gamma counter (LKB Instruments Inc., Gaithersburg, MD).  The 
percent specific 51Cr release was calculated as follows: % Cytolysis = 
(Sample -  Spontaneous)/(Maximum -  Spontaneous)  ￿  100. 
Quantification of Arthritis.  The  severity  of arthritis  was  mea- 
sured three times a week for a period of 6  mo as previously de- 
scribed  (11).  Briefly,  the severity of arthritis was  measured  on a 
scale of 0-3 for each paw (0, no arthritis; 1, mild inflammation in 
one or two  fingers;  2,  moderate  inflammation in three or more 
fingers;  and  3,  ankylosis).  Thus,  the  score  for  a  single  animal 
could vary from 0-12 depending on the severity of arthritis. 
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Figure 2.  HLA-B27 expression  on PBL in [32m  +/+'+/  and  /  mice 
by using ME-1 mAb by fluorocytometry. Cells from B27+~2m  /  mice 
show expression  similar  to  nontransgenic B10  controls  (overlapped  on 
B27+[~2m-/-). Cells  from B27+~32m  +/-  animals  show intermediate ex- 
pression  of HLA-B27.  Cell-surface  expression  was  also undetectable by 
using HC-10, Ye-2, and B27M1 mAb on PBLs from B27+I32m  -/- ani- 
mals (data not shown). 
Results and Discussion 
Generation of B27+ /32m  -/-  Mice.  As described in Mate- 
rials  and  Methods,  B27+[32  m-/-  animals  were  identified 
from  the  ([32m  -/-  ￿  HLA-B27)F2  population  and  inter- 
crossed to produce the line (Fig.  1, A  and B). The presence 
of the HLA-B27  transgene in the  [32m  -/-  background was 
confirmed  by  PCR.  Cell-surface  expression  of the  trans- 
gene product either on splenocytes or on PBLs was not de- 
tected  by  using several HLA-B27--specific  antibodies  (Fig. 
2).  Metabolic labeling of the spleen cells by 35S and immu- 
noprecipitation  showed  monomers  of heavy  chains  (HCs) 
Figure  1.  Generation  of B27+132m  -/-  mice.  Transgenic  HLA-B27 
mice were mated with 132m  -/- mice, and B27 positive offspring were in- 
tercrossed  to produce B27+132m  -/-  mice.  In this figure,  A  and B gels 
show PCR analysis for the identification of HLA-B27 transgene and ho- 
mozygous  mutant 132-microglobulin,  respectively  (6,  8).  Lane  I,  non- 
transgenic  control B10 mice show normal wild-type [32m and no B27; 
lane 2,  mutated ~2m from ~2m  -/-  mice; lane  3,  HLA-B27  transgenic 
mice show presence orB27 gene and wild-type ~2m; lane 4, B27+~am  +/ 
-  offspring from (HLA-B27 X ~2m-/-)F1 cross show the B27 gene with 
normal and mutated ~2m; lane 5, B27+~2m  -/- animals from the F  2 pop- 
ulation show the B27 gene and mutated ~2m. 
Figure 3.  Lateral views of the peripheral joint of arthritic B27+~32m  -/- 
(A) and nonarthritic B27-132m  -/- (/3) full sibs. Mild arthritis with swelling 
in one toe of the left hind paw in B27+132m  -/- mice started  3 wk after 
transferring  from a barrier facility to a conventional colony.  17 d after the 
first symptom of arthritis, joint ankylosis was noticed. At this time, the 
right hind paw was also affected with arthritis.  Other male B27+132m  -/- 
mice from the same cage also exhibited similar symptoms. 
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latation (C and D) and hyperkeratosis. 10 d after transferring  from the barrier facility  to a conventional  colony, a vascular  dilatation  and darkness in a nail 
of the rear paw was noticed. Within 5-7 d, this darkness in the nail  changed to hyperkeratosis, and ultimately  the nail  fell off. 
of HLA-B27  (data not shown).  The  copy number of the 
HLA-B27 gene was found to be between 4  and 8.  Similar 
to [32m-deficient mice (8), B27+[32m  -/- mice have a negli- 
gible number of CD8 +  T  cells but a normal repertoire of 
CD4 + T  cells. 
Spontaneous  Inflammatory Disease in  B27+~2 m-l-  Mice. 
The mice were healthy and normal as long as they stayed in 
our pathogen-free colony. Within 2-4 wk after transfer to 
a conventional  mouse colony, spontaneous development of 
nail and joint changes was observed in B27+[32m  -/-  mice 
but not in B27 +  ([~2  m+/-' +/+)  or B27-  ([32nl  +/-, -/-) lit- 
termates. Clinical arthritis began with redness and swelling 
in a single toe of the rear paw.  This progressed to involve 
both  hind  paws  with  swelling,  deformity,  and  ankylosis 
(Fig.  3).  Nail  changes  were  observed  primarily in  male 
mice at the onset of clinical arthritis (Fig. 4). 33 of 44 (75%) 
male mice, 4 mo or older, developed spontaneous arthritis 
in comparison to 7 of the 23 (30%)  female mice (Table 1). 
Female mice developed milder arthritis with a delayed on- 
set. About 40% of arthritic male animals showed ankylosis 
in at least one of their rear paws. The other mice developed 
a milder form of arthritis involving  swelling in one or both 
rear paws.  Front paws were unaffected in most of the dis- 
eased animals. These findings are similar to HLA-B27-re- 
lated arthropathies in humans (12). Histological changes in 
arthritic mice were characterized by synovial cell prolifera- 
tion, cartilage and subchondral bone erosions, and mono- 
nuclear cell proliferation (Fig. 5). Preliminary data show no 
occurrence of such symptoms in HLA-Cw3+[32  m-/- mice. 
Cultures for tested microorganisms inside and outside the 
barrier facility showed no difference (data not shown). Pre- 
liminary analysis for the presence of arthritis causing Myco- 
plasma strains such as Mycoplasma arthritidis and M. pulmonis 
were  negative  (courtesy  of Dr.  B.  Cole,  University of 
Utah, Salt Lake City, UT). 
Table 1.  Spontaneous  Arthritis in B27  + ~2  m-l- Mice 
No. of  Mean 
No. of  arthritic  arthritis  Nail 
Mice  Sex  Mice  mice  severity  changes 
[32m  -/-  M  38  -  -  - 
F  29  -  -  - 
B27 + ~2m  +/+  M  43  -  -  - 
F  34  -  -  - 
B27+[32m  -/-  M  44  33 (75%)  3.0 --_ 1.7  22 
F  23  7 (30%)  1.6 +  0.5  2 
B27-[32  m-/-  M  19  1(?)  -  - 
littermates  F  13  -  -  - 
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toreactive to the HLA-B27 molecule. Expansion of CD8 + 
T  ceils was not observed in the peripheral blood of arthritic 
mice. 
Aberrant processing of B27  HCs  could also  lead  to  de- 
velopment of spontaneous arthritis in B27 +[32m  -/-  mice or 
in rats with a high copy number of B27 transgenes (16).  In 
the absence of [~2m or overexpression of the B27 gene, the 
class I molecules may be retained in the endoplasmic retic- 
ulum or cytoplasm. Continuous generation of such protein 
in  the  cytoplasm  would  lead  to  abnormal  accumulation. 
The unassembled HC  of HLA-B27 may present extracellu- 
Figure 5.  Histology of the arthritic hind paw of the B27+[32m  -/  mice 
3 wk after transferring from the pathogen-free barrier facility to a conven- 
tional colony. Cellular proliferation in the synovium with exudation into 
the joint cavity are shown. The presence of pannus eroding the cartilage 
and  subchondral bone is highlighted.  Hematoxylin  and eosin staining, 
3<25 (A), X50 (B), and ￿  (C). 
Potential Mechanism  for the Development of Disease.  The 
occurrence of spontaneous arthritis only in the B27+[32  m-/- 
mice  suggests  several  potential  mechanisms  in  the  disease 
process. With few exceptions (13), the HC  of MHC  class I 
molecules  binds to  [32m  and  peptides  in  the  endoplasmic 
reticulum,  and  the  trimeric  complexes  are  transported  to 
the  cell  surface  (14).  [32m-deficient  mice  do  not  express 
class  I  molecules on the  cell surface  and have  a  negligible 
number ofCD8 + T  cells because of a lack of positive selec- 
tion (8). Recently, autoreactivity of such small numbers of 
CD8 +  T  cells from  [32m-deficient mice  has been  demon- 
strated  against self-MHC  (15).  Similarly, a  low number of 
CD8 +  T  cells seen in B27+[32  m-/-  mice  could be the re- 
Figure  6.  Cell-surface expression ofHLA-B27 HC on PBLs after 48 h 
of stimulation with Con A.  (A) A shift of 5(t--70 fluorescence channels 
was  noticed  on B27+[32m  -/-  PBLs in comparison with nontransgenic 
B10 or B27q32  m-/  controls by using an HC-specific HC-10 antibody. 
Other anti-HLA-B27 mAbs did not show such increases of cell-surface 
expression. The presence of HLA-B27 on the cell surface was also con- 
firmed by using anti-B27 CTL in a cytotoxicity assay. (B) Relative cyto- 
toxicity of anti-B27 CTLs against B10, B27~[32m  +/*, B27+135n  -'-, and 
~2m  /  targets at 10:1 E/T ratio. 
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Degraded products of HLA-B27 proteins may behave as an 
autoantigen and could be presented by the class II molecule 
to a CD4 + T  cell. Exposure of these mice to environmen- 
tal antigens with molecular mimicry could break self toler- 
ance and may be the cause of disease development (18). 
Even  though  normal  expression  of B27  is  observed  in 
patients,  a defect in expression could have occurred during 
ontogeny or early childhood,  causing positive selection  of 
self-reactive  T  cells.  Mutation  in  132m (19)  and polymor- 
phism  in peptide  transporter  (20,  21)  or proteosome  (22) 
genes could also result in selective peptide binding,  ineffi- 
cient processing and  reduced  transport  of B27  molecules, 
and perturbation  of T  cell repertoire.  Thus, abnormal pro- 
cessing,  transport,  and  expression  of HLA-B27 could pre- 
dispose certain B27 § individuals to spondyloarthropathies. 
To determine whether the HLA-B27 molecule may reach 
the  cell  surface  in  B27+[32m  -/-  mice,  splenocytes  were 
stimulated in vitro, and expression of free HCs of B27 was 
determined.  Low-level expression of the HC of HLA-B27 
was detected on the cell surface of Con A-stimulated sple- 
nocytes  (Fig.  6  A).  The  presence  of HLA-B27  HCs  on 
Con A-stimulated splenocytes was further confirmed when 
>50%  lysis  of B27+j32m  -/-  targets  was  seen  with  anti- 
HLA-B27  CTLs  in  a  51Cr  release  assay  (Fig.  6  B).  The 
presence  of HCs on the  cell surface after stimulation  sug- 
gests  several  scenarios:  (a)  Environmental  antigens  in  the 
conventional  colony  may  stimulate  cells  to  express  free 
HCs on the cell surface, (b) the presentation of extracellular 
peptide to residual CD8 + T  cells,  and (c) expansion of self- 
reactive T  cells  that could be autoreactive  to self-MHC as 
shown  in  ~2m-deficient  mice  (15).  Studies  are  currently 
underway  to  determine  the  mechanism  involved  in  the 
progression of disease in these mice. 
In conclusion,  our results  clearly demonstrate  a  specific 
role for the B27 molecule in disease.  It is obvious, though, 
that  additional  genetic  factors  and  environmental  triggers 
are  required  for  the  onset  of autoimmunity.  The  occur- 
rence of the disease in B27+[32m  -/-  mice suggests a possi- 
ble role for aberrant  expression of HLA-B27 in predispos- 
ing  the  mice  to  self reactivity.  This  mouse  model  opens 
several new avenues to further dissect the role of HLA-B27 
in  the  disease  process,  since  proteosome  and  transporter 
knockout  animals  are  now available.  Specificity of HLA- 
B27  association  with  this  disease  can be  further  tested  by 
using other unrelated  HLA class  I  transgenic  mice  (HLA- 
A3, HLA-B7) in the absence of [32m. We can also generate 
new transgenic mice with a non-disease-associated B'2703 
or mutated B27 genes.  In addition,  a systematic analysis of 
the  environmental  agents  involved  in  the  disease  trigger 
could pave the way for identification of the exogenous an- 
tigen  and  generation  of vaccines  and  immunotherapeutic 
agents.  We believe  that rapid progress  can be made in the 
understanding  of  the  disease  mechanism  in  HLA-B27- 
linked spondyloarthropathies using this mouse model. 
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